文献速递免疫规划卫生政策与健康促进

全球疫苗缺货:必需疫苗是否总能在需要时获得?

Vaccine stockouts around the world: Are essential vaccines always available when needed?
PubMed 文献 · Vaccine · 2017-01-01

该研究基于2011至2015年WHO-UNICEF联合报告表和UNICEF疫苗预测工具的数据,分析各国疫苗缺货的发生率、根本原因及对服务提供的影响。结果显示平均每年每三个WHO成员国中就有一个经历至少一种疫苗至少一个月的缺货,撒哈拉以南非洲最为突出,国家层面缺货80%源于国内原因,且国家层面缺货导致地区层面缺货的概率为89%,地区层面缺货导致接种服务中断的概率为96%。

要点

  • 平均每年每三个WHO成员国中就有一个经历至少一种疫苗至少一个月的缺货。
  • 撒哈拉以南非洲38%的国家报告国家层面缺货,含DTP疫苗和BCG分别占缺货事件的43%和31%。
  • 国家层面缺货80%源于国内原因,其中政府资金延迟占39%、采购流程延迟占23%、预测和库存管理不善占18%。

核心结论

  • 确保必需疫苗持续可获得仍存在重要挑战,全球社会与各国急需设计有效干预措施以减少缺货频率并减轻其影响。

研究设计与样本

  • 分析WHO-UNICEF联合报告表与UNICEF疫苗预测工具中2011至2015年(以2010年为基线年)的疫苗缺货指标。

主要发现

  • 平均每年每三个WHO成员国中就有一个经历至少一种疫苗至少一个月的缺货。
  • 撒哈拉以南非洲38%的国家报告国家层面缺货,为缺货发生率最突出的地区。
  • 含DTP疫苗和BCG分别占报告缺货事件的43%和31%,为国家层面缺货最受影响的疫苗。
  • 国家层面缺货80%源于国内原因:政府资金延迟占39%、采购流程延迟占23%、国家层面预测和库存管理不善占18%。
  • 国家层面缺货时地区层面缺货的概率为89%,地区层面缺货导致接种服务中断的概率为96%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: As countries rise to the challenge of implementing the priorities of this "Decade of Vaccine" and their commitments delineated in the Global Vaccine Action Plan (GVAP), many continue to face important challenges of securing a continuous supply of essential vaccine for their national immunization programme. This study provides evidence on the incidence of vaccine stockouts in countries, their root causes and their potential impact on service delivery. METHODS: Vaccine stockout indicators collected from the WHO-UNICEF Joint Reporting Form (JRF) and UNICEF's Vaccine Forecasting Tool were analysed for the years covering the first half of the GVAP (2011 to 2015) and using 2010 as the baseline year. While the JRF collects annual information on national and subnational stockouts by vaccine, the UNICEF Vaccine Forecasting Tool has the advantage of requesting UNICEF procuring countries to report on the reasons underpinning any stockouts. RESULTS: Every year on average, one in every three WHO Member States experiences at least one stockout of at least one vaccine for at least one month. The incidence is most pronounced in Sub-Saharan Africa where 38% of countries in this area of the world report national-level stockouts. The vaccines most affected are DTP containing vaccines (often combined with HepB and Hib) and BCG. They account for respectively 43% and 31% of stockout events reported. While national level vaccine stockouts occur in countries of all income groups, middle income countries are the most affected. In 80% of cases, national level stockouts were due to reasons internal to countries. More specifically, 39% of stockouts were attributable to government funding delays, 23% were caused by delays in the procurement processes, and poor forecasting and stock management at country level accounted for an additional 18%. When a national level stockout of vaccines occurs, there is an 89% chance that a subnational stockout will occur at district level. More concerning is that if a district level stockout occurs, this will lead to an interruption of vaccination services in 96% of cases. DISCUSSION: There continues to be important challenges of ensuring a continuous availability of essential vaccines. The global community, together with countries, urgently need to design effective interventions aimed at reducing the frequency and mitigating the impact of stockouts.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lydon P, Schreiber B, Gasca A, et al. Vaccine stockouts around the world: Are essential vaccines always available when needed? Vaccine. 2017. PMID: 28364919. doi:10.1016/j.vaccine.2016.12.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。